Kevin Foley
Company: Ranok Therapeutics
Job title: Co-founder & Chief Scientific Officer
Seminars:
Panel : Debating the Therapeutics Utility of PROTACs & Molecular Glues versus Direct Targeting of RAS to Strategies Best-in-Class Therapeutic Interventions 12:15 pm
day: Day Two Track A AM
Addressing mKRAS Inhibitor Resistance with Hetero-Bifunctional mKRAS-HSP90 CHAMPs 2:15 pm
day: Day One Track A PM